Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 65

Remifentanil With or Without Lidocaine for Extubation After Thyroid Surgery

Official title: Comparison of the Effects of Remifentanil and Remifentanil-Lidocaine Combination on Tracheal Extubation Quality in Patients Undergoing Thyroidectomy

Run by Pamukkale University · NCT07857356 · Data updated 2026-11-12

This study tests whether adding intravenous lidocaine to remifentanil during awakening reduces coughing after thyroidectomy extubation in adults.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorPamukkale University
Academic / other
Locations1 site (Denizli)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedNovember 2026
Study endsNovember 2026
Registry record updatedNovember 2, 2026
Trial IDNCT07857356 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 years undergoing elective thyroidectomy under general anesthesia, ASA I–II, with BMI <35 kg/m².

Probably not a fit

Patients with chronic respiratory disease, airway abnormalities, or lidocaine allergy may not benefit and could be at higher risk.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized, double-blind trial, 60 adults undergoing elective thyroidectomy will receive remifentanil during emergence from anesthesia, with half also receiving intravenous lidocaine before extubation. The study compares coughing during tracheal extubation and also looks at cough severity, vital signs, airway events, sore throat, hoarseness, nausea and vomiting, sedation, and recovery times. Outcomes will indicate if lidocaine plus remifentanil provides a smoother, safer extubation than remifentanil alone. The trial is parallel-group and conducted at Pamukkale University Hospitals. Patients meet standard anesthesia criteria and will be assessed for eligibility and safety throughout.

Why it matters

Potential benefit: If lidocaine adds benefit, patients may experience less coughing and smoother recovery after thyroidectomy extubation.

How similar studies have gone: Prior strategies using airway reflex-modulating drugs have shown reductions in coughing during extubation in similar surgical populations, though this exact lidocaine-plus-remifentanil approach is being studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 to 65 years American Society of Anesthesiologists (ASA) physical status I or II Scheduled for elective thyroidectomy under general anesthesia Body mass index (BMI) \<35 kg/m² Able to provide written informed consent

Exclusion Criteria:

* History of chronic respiratory disease, including asthma or chronic obstructive pulmonary disease (COPD) Active upper or lower respiratory tract infection Known airway abnormality or anticipated difficult airway Known allergy or hypersensitivity to lidocaine Planned postoperative intubation or extubation in the intensive care unit Refusal to participate or withdrawal of consent

Where it's running

  • Pamukkale University Hospitals
    Denizli, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.